SCHEMBL23913829

SCHEMBL23913829

c1ccc(-c2cccc3oc4cc(-c5nc(-c6cccc(-c7ccc8c(c7)sc7ccccc78)c6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.36
PRKDC P78527 1/20 0.35
F9 P00740 1/20 0.34
BACE1 P56817 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
PLA2G10 O15496 1/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 1/20 0.33
AHR P35869 1/20 0.33
ALOX5 P09917 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913436 0.97 HCRTR1 (0.35) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL22763946 0.97 PRKDC (0.36) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL25851901 0.96 PRKDC (0.35) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL23913825 0.95 HCRTR1 (0.35) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL25459332 0.94 PRKDC (0.38) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL25459329 0.94 PRKDC (0.37) HCRTR1PRKDCF9PLA2G2APLA2G4A
SCHEMBL22763907 0.93 PRKDC (0.36) HCRTR1PRKDCF9BACE1ALDH1A1
SCHEMBL25557573 0.93 ALOX5 (0.36) HCRTR1PRKDCF9BACE1PLA2G2A
SCHEMBL24315476 0.93 F9 (0.37) PRKDCF9BACE1ALDH1A1HPGD
SCHEMBL23821599 0.93 PRKDC (0.35) HCRTR1PRKDCF9BACE1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 HCRTR1 476/4885PRKDC 4327/4885F9 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.